Mogy Joel R Investment Counsel Inc. Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mogy Joel R Investment Counsel Inc. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 66,906 shares of the medical equipment provider’s stock after acquiring an additional 800 shares during the quarter. Intuitive Surgical accounts for 2.1% of Mogy Joel R Investment Counsel Inc.’s investment portfolio, making the stock its 16th largest holding. Mogy Joel R Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $34,922,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. State Street Corp increased its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares during the period. FMR LLC grew its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Geode Capital Management LLC lifted its position in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC boosted its stake in shares of Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. grew its holdings in shares of Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,509 shares of company stock valued at $22,602,212 in the last three months. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 1.5 %

NASDAQ:ISRG opened at $592.64 on Tuesday. The stock has a 50-day moving average price of $541.80 and a 200 day moving average price of $500.76. The stock has a market capitalization of $211.09 billion, a P/E ratio of 95.28, a P/E/G ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Truist Financial increased their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Citigroup increased their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Finally, Raymond James boosted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.